Nanocarriers with passive or active targeting capabilities have been utilized for improved delivery of anti-inflammatory agents, achieving synchronous drug release via encapsulation of diverse prodrugs [62, 86, 87]
However, with aging, LCs migrate less to nearby lymph nodes, which can result in reduced immune surveillance among the elderly (48)
[9] The mechanism appears to involve direct GHS-R1a receptor activation on cardiac cells independent of GH release, since hexarelin (a related GHRP) showed cardioprotective effects even in GH-deficient models
Under the supervision of our mentor Mr
Glucagon like peptide 1 receptor agonists in the treatment of obesity
This protein, which was upregulated 2.2-fold (p=0.041) in semaglutide-treated animals, catalyzes the rate-limiting step of nitric oxide synthesis